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INTRODUCTION
Whatever the merits of the pros and cons of
present day debates concerning manned space explo-
ration, results of clinical studies of radiation
effects in man himself do not support the conten-
tion that man is too radiosensitive an animal for
this task. Man, other animals, electrical
components, machines, etc. are all radiosensitive
but have different tolerance levels that can be
measured by the failure probabilities of variously
performing systems. These may be immediately or
only remotely important biologically or operation-
ally. Evaluation of the space radiation hazards to
man depend equally upon the accuracy of our physic_
knowledge of the levels and kinds of radiation that
he may encounter and our biological knowledge of
human radiation responses. Biologically, our
knowledge is qualitatively good but not quantita-
tively accurate for man. Most quantitative
radiobiologic estimates must be extrapolated from
or with the aid of studies in animals where
radiation exposures can be controlled experimen-
tally and radiation effects quantitated by
destructive techniques not applicable to clinical
studies. The suitability of these animal models
for prediction of the kinds and levels of human
responses has been gauged by many clinical studies
iThe studies upon which this chapter is based have
been supported since 1959 chiefly by the USAEC
and augmented by NASA since 1964.
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of victims of radiation accidents and of patients
undergoing elective radiation exposure in the
therapy of their disease. Unfortunately, for our
purposes, there have been few radiation accidents
where men have been exposed to known amounts of
radiation. On the other hand, in therapeutic ex-
posures, although the dose is well known, the
radiation effects are often confused by the pre-
existing disease process.
Never the less, my associates 2 and I have been
directing the major part of our efforts at the
Medical Division in Oak Ridge toward defining human
radiosensitivity from such clinical studies of
radiation effects (refs. 1 - 9). These studies
were begun in 1959 when our first human total-body
irradiator was constructed for radiotherapy of
patients with uniform exposures to omnidirectional
beams from an array of gamma ray emitting radioiso-
tope sources. Since then, with the continuing
support of the AEC and with support from NASA
commencing in 1964, we have expanded these studies
of human therapeutic and biologic effects of
single rapidly delivered exposures with low dose
2Gould A. Andrews, R. M. Kniseley, C. Lowell
Edwards, R. Tanida, F. Goswitz, Frank Comas,
H. Vodopick, E. Balish, G. Kingdon, G. Littlefield,
R. Ricks, W. Beck, T. Stokes, P. Aaron, E. Frome,
E. McDow, A. Webb, A. Sipe, Mrs. Sutliff, and
support staff.
https://ntrs.nasa.gov/search.jsp?R=19720010003 2020-03-17T03:49:18+00:00Z
rate exposure studies of protracted or fractionated
radiation effects. Here we are now using another
facility (Fig. 1) constructed solely for such ex-
posures which in some instances have taken as long
as ten days -- about the time for a round-trip
lunar exploration. Coincidentally, the skin dose
from 60Co gamma rays in this low-exposure-rate
total-body irradiation facility ("LETBI") accumu-
lates with 1.S R/hr exposures: the same rate that
skin dose from protons would have, according to
Dye ahd Wilkinson (ref. 10), in the worst week ever
recorded for solar flare activity in space. As can
be seen in Figure 2, derived from their study, the
intestinal doses from the therapeutic and solar
forms of irradiation and their respective rates of
accumulation are widely divergent. The relatively
small accumulated intestinal dose from solar
protons offers little or no chance for untoward
physiologic effects occurring from such radiation
exposures in space.
We have broadened these direct therapeutic
observations where possible by retrospective studies
of clinical data obtained from other American and
Canadian investigators and radiotherapists who
kindly made these data available to this project.
To obtain some basis for relating these results
obtained with photons to those that might occur
after exposure to high LET particles, we have been
following closely the continuing studies of the
ABCC staff at Hiroshima on the effects of mixed
fission neutron and gamma irradiation that occurred
in the Japanese atom bombings (see later).
This paper could end right here if the
question to be answered for determining permissible
exposures in space was only: What is the photon
flux that "man" can "tolerate" and function in,
while living under almost continuous exposure
Figure i. Cut-away diagram of the low dose-rate_ total-body
irradiation facility used in Oak Ridge to study the effects
of protracted exposures (I00 to 2S0 R of 6%o gamma rays
accululated at 1.5 R/hr for S to I0 days). The location of
some of the eight 26 Ci sources are shown (nu_ered) with the
smaller tricing sources (C and F) s_rounding the inner
treatment roog where the patleut resides. The control room
and data processing areas are adjacent to the 36 x 36 x 18 ft
radiation containment room.
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Figure 2. The rate of dose accumulations in the skin and
intestinal tract of patients exposed to 1.5 R of 60Co gamma
rays/hr contrasted with those estimated for those organs of
an hypothetical astronaut shielded by a space vehicle in the
solar proton fluxes that occurred between 10 and 17 July 1959.
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conditions? We know that patients (ours as well as
•others) "tolerate" total accumulated exposures of
photons up to 250 R (average [estimated] bone mar-
row doses of 150 rads) and daily exposures at rates
of 28 to 33 R at l.S R/hr. "Toleration" here, of
course, is used by me at the subjective level; only
a rare patient under these exposure conditions has
shown gastrointestinal distress or complained of
being sick or tired. Hematologically, however,
exposures of this magnitude cause therapeutic
depressions in blood leukocyte or platelet levels;
percentage-depressions that would not be desirable
from an occupational medicine point of view.
Recently, as reported in another paper (ref. ii) in
this symposium, we have demonstrated, using physio-
logic monitoring, that, unbeknowst to the patient
being irradiated at these "tolerance" levels, he
becomes exercise-intolerant or more easily fatigable
even though no symptoms of the prodromal radiation
syndrome or GI sickness occur. Although we believe
we are defining in these retrospective and on-going
studies a less-than-ten-day continuous irradiation
"tolerance" level for man, we also know that many
more human observations are needed before we can
predict with certainty how radiosensitivity of
various biologic systems change when exposures occur
slowly over extremely large time periods an.d to
relatively non-reparable high LET radiations. The
late biologic consequences of irregular, numerous
small exposures to high, as well as low, LET
particular radiations remain our most serious
problem because they are the restrictive criteria
on which safe levels of occupational exposures must
rest.
The word "tolerance," of course, has many def-
initions and many inferences that change in relation
to the bodily functions being considered. The term
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is used by me as the biologic summation of initial
response, recovery from damage, and ignorable
damage remaining in the total body or a specific
organ system for various periods of time. For
example, the one most commonly used level of radia-
tion tolerance for any animal species is its
radiation-induced lethality expressed in terms of
the exposure (R) or dose (rads) that is expected to
kill 50% of that kind of animals within 30 or more
days (LD50/30; LD50/60).
THE HUMAN LETHAL DOSE PROBLEM
There is world-wide willingness to accept the
estimate that the dose that will kill the unattended
normal man with 50 percent certainty within 60 days
of exposure (LDs0/60) is 450 R and that the
mechanism of death is damage to his hematopoietic
system and defense mechanisms against infection.
The degree of acceptance of this 450-R value is
surprisingly high in view of its history and its
lack of valid support from reported human data
(ref. 12). The importance of establishing this
number for man was recognized during and immediately
after World War II (ref. 13). It is the obvious
point of reference for relating the radiosensitivity
of man to that of other mammals whose radiation
sensitivity has been well established by years of
extensive research - most commonly by determining
precisely the LDs0 and its confidence limits for
the species (ref. 14). This number, which is re-
producible experimentally in laboratories around
the world for each species, has rightly become the
simpliest expresslon for mammalian radiosensitivity.
Because of the ease of its experimental determina-
tion, it has also become the end point most commonly
used in radiobiological studies of relative effec-
tiveness of various kinds of ionizing and nonioniz-
ing radiations and various kinds of radioprotective
agentsandpostirradiationtherapy.
Justhowthis estimate of 450 R for man's
total-body radiation tolerance was made has never
been revealed publically. The assumption has been
made (ref. I5) that Warren and Bowers based their
estimate on lethality data obtained by the Joint
Commission of the Medical Departments of the U. S.
Army, Navy, and the Manhattan Engineering District
in Japan during 194S. Host such accounts must be
apocryphal since there was a tenfold error in the
Hiroshima bomb-yield estimates that would have
biased this number upwards and made it impossible
to reconcile with the lower exposures in Nagasaki.
These corrections, called "T65 doses" (ref. 16) are
the ones now in use at ABCC in retrospective eval-
uation of human responses in these bombings.
Attempts to increase this estimate to 600 R,
in the belief that the suggested human LD50/60
implied a depth dose of 450 rads of photon energy,
have been fought off successfully by several
investigators, notably by Cronkite and Bond (ref.
17) on the basis of their observations of the
hematopoietic responses of the Marshallese natives,
inadvertently irradiated by fallout after a Bikini
atom bomb test (ref. 18).
The LD50 , by definition, forms the best single
measurement of the upper or acute lethal boundary
of total-body radiation tolerance (see Fig. 3).
There have been several attempts to check the 450-R
estimate from human case histories after both acci-
dental and intentional radiation exposures. These
are tabulated in Table 1 to show how all studies
have produced values lower than the original esti-
mate and seem to indicate that 450 R is too high to
be considered an estimate of midline depth-dose
(absorbed radiation energy). The table also in-
cludes the results of two recent attempts to obtain
Table 1
EDUCATED GUESSES AND SOME CLINICAL AND STATISTICAL
ESTIMATES OF HUMAN TOTAL-BODY RADIATION TOLERANCE
A. NORMAL MAN
I. Warren and Bowers (ref. 12)
2. Cronkite and Bond (ref. 17)
3. Langham (ref. 15)
4. Jablon et al. (ref. 19)
B. PATIENTS
I. Math6 et al. (ref. 20)
2. Langham (ref. 15)
3. Lushbaugh et al. (ref. 4)
C. NORMAL MAN + BLAST
AND BURN TRAUMA
I. Lushbaugh and Auxier (ref. 21)
*RBE for fission neutron component = S.
%RBE for fission neutron component = 2.
LDs0/60
Exposure Dose
450 R
550 tad
430 R
405 rem*
400 R
2;80 R
370 R
260 rem*
(285 tad)
(250 rad)
(245 tad)
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Figure 3. Acute hemopoietic syndrome is defined graphically
by estimates of effective single doses for radiation-induced
anorexia and lethality in patients. The probit regression
lines have shaded fiducial limits. Depth dose is shown in
"epigastric" fads to indicate that it is the fraction of the
free field of photon radiation absorbed in the midline,
midplane of the upper abdomen. This reference dose is usually
64 to 68 percent of the exposure in an average-sized man.
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estimates of the human LD50 from the Hiroshima-
Nagasaki exposures to mixed fission neutrons and
gamma radiation (refs. 21 and 19). Many large
animal experiments using fission neutrons, partic-
ularly those of Alpen (ref. 22) and Bond (ref. 23)
and co-workers have provided a strong basis for
forming the opinion that in "large" animals like
man, dogs, swine, and cattle the RBE or QF for high
LET radiation is 1.0 for acute hematopoietic death
(ref. 15). In studies of human dermal responses to
fast neutrons (refs. 24 and 25), RBE values of from
2 to 4 are needed, as in lower animals, to equate
neutron dose for skin erythema with that of the
reference (low LET) radiation. A QF value of 3 for
high LET radiation (>3.5 keV/_) has, however, been
suggested only for damage to skin, intestines, and
germinal epithelium (and not for prodromal responses,
early hematologic responses, as well as hemato-
poietic death [ref. 15]). This recommendation seems
to me to depreciate the well-known, experimentally-
proven fact that sublethal cellular injury induced
by high LET radiations is irreparable and as perma-
nent as the cell in which it occurred. It would
seem biologically more conservative, particularly
from a safety point of view, to assume that in humal
tissues, including marrow, the damage caused by a
dose of high LET radiation would be poorly repaired
as it is in similar small animal tissues, and that
hematopoietic as well as skin and intestinal crypt
stem-cells would suffer equall 7 in respect to
actual dose from the same high LET radiation.
The answer to this problem is still disputable,
but the more recent observations in the Japanese
lend weight to the other side of the question for
the first time. Lushbaugh and Auxier (ref. 21)
used data from an unpublished study of the effects
of various kinds of shielding upon survival in both
cities in relation to the T-65 dose estimates of
the free-field fluxes at the 50 percent survival
points. They obtained an LDs0 estimate of 260 rem
using an RBH of 2. This estimate was expected to
be low because it should reflect the additive
effects of heat and blast combined with radiation-
induced damage. The more recent study by Jablon
et al. (ref. 19), relates the estimated individ-
ualized doses received by _i00,000 survivors in the
two cities with their clinical history of epilation
and oropharyngeal hemorrhages. The human pharyngeal-
epithelial and tonsillar-adenoidal barriers to
infection have not been given much consideration in
recent discussions of the acute hematopoietic
syndrome. Yet it is an excellent objective end
point for measurement. This painful, hemorrhagic
sore throat is a symptom complex known as agranulo-
cytic angina that stems from pharyngeal ulceration,
bacterial invasion, granulocytopenia, and thrombo-
cyt0penia. By using this system complex as the
measurable quantum of damage from total-body
irradiation, any additive effect of other forms of
concomitant tratLma was avoided in the ABCC study.
As can be seen in Table 2, the isoeffective expo-
sures are only equal in rem when an RBH much greater
than unity is used for the neutron component of the
exposures. The isoeffective exposure dose (HDs0)
of 405 rem that was found is remarkably close to
the original human LD50 estimate. It is an even
closer estimate of the exposure field strength that
would be required for a mid-line human dose of 285
to 300 fads suggested as the possible human LDs0/60
by Langham (ref. 15) and Cronkite and Bond (ref.
17). The 310 rem, estimated as the isoeffective
estimated dose for epilation in both cities using
an RBH of 4 for neutrons, is likewise remarkably
close to the widely accepted clinical value of 300 R
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Table 2
FIFTY-PERCENT ISOEFFECTIVE EXPOSURE DOSES
FOR HUMAN SKIN AND BONE-MARKOW DAMAGE, ESTIMATED IN SURVIVORS
OF NEUTRON AND GAMMA IRRADIATION IN HIROSHIHA (H) AND NAGASAKI (N)
Resulting Estimates of
Neutron RBE Used Isoeffective Doses*
H N
(rem)
Epi 1 at ion 1 190 300
4 ÷310 310+
5 350 310
Hemorrhage 1 200 575
4 360 590
5 -_4OS 405÷
*Approximated from graphic data of ABCC Study by Jablon et al.
(ref. 19).
of X radiation as the radiation exposure causing
epilation in man. These correspondences seem to
demonstrate an internal consistency in the data and
their analyses that indicates, to me at least, that
neutrons do have an RBE greater than 1.0 for acute
hematologic, as well as for skin, effects in man.
It would seem difficult to pass the ABCC study off
lightly because it does not agree with large animal
observations. We should not ignore Math6's obser-
vation (ref. 20) that the man who died after
neutron exposure in the Yugoslavian radiation acci-
dent had much more extensive marrow destruction
than was to be expected on the basis of his estima-
ted dose of 430 rads. There seems to be less
official reluctance to accept the use of a large
RBE for neutrons and other high LET radiation when
late-effect end points are considered. Most
fractional-cell-survival studies demonstrate well
the relative irreparability of sublethal cellular
damage after high LET radiation exposure and
provide a firm experimental basis for assuming a
large QF for such effects as genetic damage,
leukemogenesis, and carcinogenesis after single
exposures. When coupled with the decrease in
405
"damage efficiency" that occurs in most biologic
systems with increasing protraction or fractiona-
tion of the same total exposure, the RBE increases
further Cref. 26]. There is not much clinical in_
formation about high LET radiation in man other than
that about the well_known effects of alpha-particle
exposures in victims of radium poisoning and in
uranium miners. The data under study by ABCC pro-
vides unquestionable verification for the large QF
for fission neutrons for leukemogenesis and thyroid
carcinogenesis (ref. 27) after single exposures.
In Figure 3 the acute hematopoietic syndrome
of irradiated man is defined as the probability of
of response estimates in respect to total-body
photon exposures. Here, probability of lethality
forms the upper bound and that of acute GI distress
of the prodromal syndrome forms the lower bound of
the envelope. How these dose-response relations
shift when exposure is prolonged or fractionated is
our continuing problem.
Retrospective studies of a large volume of
clinical data extracted from hospital charts of
2000 patients given therapeutic total-body irradia-
tion have given us dose-response relations for the
symptoms and signs of the prodromal syndrome. The
statistically determined single exposures that can
be expected to produce these symptoms in 50 percent
of the patients so exposed are shown in Table 3
along with the increased levels of the exposure
required for the same incidence when the exposure
period is lengthened.
When total-body exposure occurs promptly in
less than one day, the effective dose for 50 percent
incidence of these response (ED50) are: anorexia,
147 R; nausea, 210 R; vomiting, 277 R; and diarrhea,
548 R. The log-normal frequency distribution of
these responses in respect to dose indicates that
Table 3
ACCUMULATEDESTIMATEDEXPOSURES*FOR
50 PERCENTINCIDENCEOF PHYSIOLOGICSYMPTOMS
Exposure Length
(Number of Patients)
<i Day <8 Days >8 Days
(504) (i03) (i083)
(R)
Anorexia 147 309 600?
Nausea 210 397 750?
Vomiting 277 745 >9002
Fatigue 223 400?
Diarrhea 348 800
*Midline upper abdominal dose (RAD = 0.66 Exposure R).
? = Guesstimate; 20 to 30 R/day is apparent threshold of dose rate.
the exposures required for their 10-percent incidence
would be about one-fourth of that for a 50-percent
incidence (ref. 4). The probability dose-response
curves predicting the population incidence of these
responses are steepest for anorexia and become
progressively less steep for nausea, vomiting, and
diarrhea in that order. This family-like relation-
ship of the probability curves for the occurrence
of the effects from mild to severe suggests that
individual variatinn in ability to repair the under-
lying physiologic damage is progressively greater
for each step in severity. If true, this analysis
predicts that a radiosensitive person who shows, for
example, nausea at a low dose would be more likely
to show other symptoms and signs of greater damage
per unit of irradiation than a radioresistant
person in whom nausea did not occur without a much
greater exposure. Except for the low-radiation-
damage threshold of the human spermatogonia type B
of about 15 rads, these gastrointestinal physiologic
effects are the most radioresponsive. In the con-
text of space exploration, these early gastrointes-
tinal effects appear to be the most likely symptoms
to occur with small exposures and therefore to be
the most likely to reduce performance capabilities.
Their occurrence would be improbable, however,
when the exposing radiation flux was less than
20-30 R/day and the radiation was poorly penetra-
ting, two conditions that_ on the basis of previous
space radiation measurements, seem to have a high
probability. Nothing is known to suggest an RBE
for high LET radiation for production of these
physiologic effects. Although one might guess that
the quality factor (QF) might be greater than thre%
the results of studies on the effect of dose pro-
traction upon the size of the effective exposure
dose (shown in Table 3) in 1,085 patients given
small, daily total-body exposures, suggest that
between 20-30 R/day are required for 30 or more
days to cause these symptoms; exposures of from 10
to 20 R/day produced nausea infrequently even when
these exposures were delivered rapidly at approxi-
mately daily intervals for three to four weeks;
exposures of about 5 to 6 R.day were physiologically
symptomless.
Although all of our statistically validated
human information in this ares i.s derived from
exposures to photons, there is no reason to believe
that fission neutrons delivered in small daily doses
for prolonged periods to the sensitive midabdominal
trigger-zone would produce damage that would ever
summate in the acute onset of gastrointestinal
distress. This opinion would seem correct, partic-
ularly if chronic exposures are constrained by
current planning limits of 0.15 rem/day through
reactor shields (ref. 15).
Recent observations obtained during the
physiologic monitoring of patients in our LETBI
unit during and after low-exposure rate (less than
406
1.5R/dayandlowtotal aaiiy exposureof less than
30 R/day) confirm these analyses of patients'
charted histories that reveal the absence of acute
GI distress finder these conditions (ref. Ii). They
indicate, however, that increased fatigability can
occur with small daily exposures of this magnitude.
These studies are still too fragmentary to be
considered a statistically sound basis for predic-
ting the incidence of radiation-induced fatigue at
low-exposure rates. So far, however, using bicycle
ergometry, we have observed performance capability
has decreased after single, prompt exposures (150 R)
and after low-exposure rate, fractionated, 15 daily
exposures of 10 R (150 R). These measurements,
based on pulmonary impedance pneumography, seem to
show that this form of performance decrement follows
a cyclic-time course with a periodicity depending
on the initial rate of induction of radiation damage.
The long duration of the effect after one exposure
could conceivably be enhanced by subsequent,
remotely-spaced exposures but we are uncertain of
this. This effect could be a threat to performance
during long-duration space missions if small radia-
tion exposures and muscular inactivity worked
together to reduce physical strength and conditionin_
EFFECT OF MULTIPLE EXPOSURES ON LETHALITY
Almost nothing is known in truly quantitative
terms about the effect of protraction or
fractionation of human exposures upon the size of
the isoeffective lethal dose. The Space Radiation
Study Panel used an unpublished study of Focht,
Nickson, and Langham in its evaluation of this
problem (ref. 15) to see if clinical data obtained
from the medical records of the Heublein total-body
irradiation unit, Memorial Hospital, could he fitted
to a Strandqvist-type of mathematical model. In
this retrospective study the relative roles of the
basic disease and of the protracted low-dose-rate
radiation in causing death could not be determined.
Whether or not a patient died during or within 60
days of his treatment was recorded only as yes or
no quantal information and graphed in relation to
total accumulated exposure and duration of exposure.
The three graphic areas defined by exposure and
time were delineated by the incidences for >90%
death, 50% death, <10% death. The best fit of
these data to three parallel lines for the 90, 50,
and 10% probabilities of death were then computed
by Langham (unpublished) using a "Strandqvist"
(ref. 28) power function model:
Isoeffective (fractionated) LDs0 = 345 t 0"16
Where 345 is the assumed nominal single lethal
dose in fads (midline absorbed photon energy)
for a _protracted exposure to about 530
R of X radiation over one week; t is used for
exposures longer than 1 week's duration and
the exponent of t is the power-function or
slope constant of the log-log regression line.
This model and its parameters were graphed (Fig. 4)
by the author to show how this model predicts these
isoeffective lethal dosage levels (90, 50, and 10%)
will increase with increasing durations of exposure
up to a year. The amount of repair predicted by
this model for photon irradiation is remarkable.
It is of interest that the power function (or slope
constant) derived from the best fits was 0.26, a
number remarkably similar to that factor for normal
skin damage and tumor cures (ref. 28) and hemato-
logic damage (ref. 29). As shown in the figure,
this model predicts 50% survival at 18 rads/wk or
%3 rads (marrow dose)/day/year. The slope of this
regression line for increase in LD50 , as marrow
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LASL MODEL OF HUMAN LETHALITY FOR FRACTIONATED
EXPOSURES-AFTER FOCHT AND NICKSON
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Figure 4. The Los Ala_OS Scientific Laboratory [LASL) model
for h_n lethality computed from clinical total-body
irradiation data of Focht and Nickson using the method of
Strandqv£st to determne the power f_ction for duration
of exposure in ueeks.
dose is protracted, would be steeper if fatal
diseases were not present in the study population.
A recent study of clinical and accident data indi-
cates that this slope may be increased as much as
2 or 3 times if the exposed persons have normal-
health hematopoietic systems (ref. 29).
Low-dose-rate exposure at tlle rate suggested
by these combined observations (about i0 R/day if
the Yuhas correction of 3 is accepted) is, however,
apparently not tolerable for man for a year. In
fact, the events in the 1964 Mexican accident can
be interpreted as demonstrating that in only 100
days of such irradiation an exposure close to that
for lethality will be accumulated at _10 R/day
(ref. 30). One of the victims in this accident
was literally irradiated to death in 115 days,
during which time she received an estimated 2,000
to 3,000 rem of cobalt-60 gamma radiation (15 to
25 R/day [see Table 4]). Her husband, who is still
surviving at the time of this writing seven years
after the accident (shown by the asterisk in Figure
4) received his daily exposures (984 to 1,717 rem
in 106 days) during the night while sleeping. His
wife and his mother were irradiated continuously
day and night as they worked about the house where
an unrecognized radiography 60Co source was stored.
The four deaths in this family of five were found
at autopsy to be from severe hematopoietic damage
that led to hemorrhage and infection. All but the
survivor acted as though they had a plague-like
disease. The survivor, however, had surprisingly
few symptoms and signs of illness in contrast to
the severe radiation-induced atrophy of his bone
marrow that was subsequently demonstrated by marrow
biopsy. What symptoms he had were chiefly refer-
rable to his low-grade anemia rather than his
severe leukopenia.
Table 4
1964 _XICAN 60C0 RADIATION ACCIDENT
0_artinez et al., 1964)
Estimated
Exposure Ex_oosure
(days) (re=)
Son 24 2940-5165
Nile I15 1996-2958
Daughter 99 1373-1872
Hother 90 1818-2897
Survivor* 106 984-1717
(Husband)
Approximate Exposure After
Rate Ranges Survival
(rein/day) (rem/hr) (daTs)
125-250 5-12 18
17-26 0.7-1 2
14-19 0.5-0.8 30
20-32 0.8-1.3 80
9-16 0.4-0.6 (7+ years)
*April 1971.
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In Figure 5, two ways are shown in which the
dose-response relations may shift when exposure is
protracted. There are: (a) a decrease in the
slopes of the shifted probability lines caused by
greater repair of radiation damage accumulated
slowly (revealed as a greater variation in the
response rates of the population); and (b) a simple
displacement of dose-response envelope without a
change in the slope of the lines for the probabi_ty
of response. This dose-response displacement is
to be expected when exposure is to high LET radia-
tion where cellular damage is nonreparable. In
Figure 6, the results are shown when the LASL
study is used to predict the level of human
lethality for the exposure rates of 6, 20, and 30
rads/wk. This probability estimate, shown by the
solid line superimposed on those of Figure 5,
supports the many observations made in mice irrad-
iated at low-dose rates that the hematopoietic
system has a remarkable ability to recover from
slowly delivered photon irradiation. Recently,
Yuhas, et al. (ref. 29) obtained additional
evidence supporting this remarkable reparability
of the normal human hematopoietic system when its
exposure is made in small fractions. He derived a
multifactorial regression model for human blood-
cell responses to multiple as well as single
total-body therapeutic exposures using approximately
2,000 clinical case histories. Individual charts
were carefully selected that met strict criteria
for numbers of blood examinations, dosimetry,
precise diagnbses, and evidence that the individual
was not in the terminal stage of his disease. The
dose-response patterns of 123 single exposures and
395 multiple exposures were studied in four diag-
nostic groups of patients: chronic myelogenous
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Figure 5. A graphic representation of two possible ways that
clinically recognizable lower and upper dose-response probability
boundaries of the hemtopoietic syndrome may shift when exposure
is protracted over a year.
A. Variance in the incidence of a response is increased as
reparability increases as after low LET photon irradiation.
B. The dose-response envelope is displaced upwards without
change in the slope of _robabillty lares, _omme_sur_te _ith
proliferation capacity of _hit target cells in the presence
of irreparably damaged targets as after exposure to high LET
particles. The prodro_l synptomatology, lower bo_d of the
prompt exposur_ probability envelope beco_s umdetectable
when the daily fraction of the exposure is less th_ 15 R
and therefore is replaced by symptoms referable to anemia
or infection. {See _able 3.)
leukemia (CHL), chronic lymphocytic leukemia (CLL),
lymphosarcoma (LS), and nonleukemic patients with
normal blood values, The percent of WBC remaining
at the nadir was found to be related to a power
function on total exposure and the duration of the
therapy in days:
% WBC = K [I00] " [D]-bl " [T]D2
K = a constant, required for extrapolation
to the ordinate at zero dose because
no effect was seen below 25 R
D = total exposure in R
bl = the slope of % WBC on D
T = the time of protraction in days
b2 = the slope of % WBC on a given D or T
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The slope of percent WBC on exposure was fotmd
to be essentially equal to -i.0 in all diagnostic
groups (Table 5). In persons with normal marrow,
percent WBC on time (T) at a given exposure (D) in-
creased as the 0.63 power of the number of days
separating the first and last fractional exposures
used. In CML, CLL, and LS this exponent was found
to be 0.39, 0.23, and 0.22.
Table 5
SLOPE CONSTANTS AND TESTS OF THE STATISTICAL
SIGNIFICANCE OF THE YUHAS _IODEL (REF. 29)
Single Exposures Multiple Exposures
Diagnostic b I Correlation b 2 Correlation P
Group Coefficients Coefficients Value
"Normal" i. 04 O. 57 O. 63 O. 535 <0. 025
CML O. 999 O. 82 O. 392 0.569 <0.0001
CLL 0.917 0.221 0.585 <0.0001
LS 1.119 O. 42 O. 251 O. 567 <0,0005
HUMAN LETHALITY AFTER ONE YEAR OF FRACTIONATED DOSAGE
(EXTRAPOLATED FROM FOCHT-NICKSON-LANGHAM)
I
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Figure6. The conjectured effect of a year-long dose protraction
upon the azsplaeement _d slope of dose-response probability
regression lides (sh_ in Figure S) contrasted with the prediction
of the LASL model using actual data. (For further explanation, see
text,)
The values for the slope constants shown in
Table 5 have biological implications: The nega-
tivity of b I indicates that as dose increases, the
percent survival of peripheral WBC decreases. The
correspondence of this value for each group to 1.0
may indicate that, in the different cellular systems
involved in these diseases, differences in radio-
sensitivity are not significant. This result is
surprising in view of the widely held clinical
belief that the leukocytes in CLLp for example, are
much more radiosensitive than the celis comprising
the WBC in CNL or in "normal" persons. This
apparent deviation from clinical "fact," however,
can be explained by the significant differences
found in the values for b 2. The larger this pos-
itive slope constant the more effective the length
of exposure protraction is in increasing percent
survival; according to these values_ in the "nor-
mal," protection of the white blood cell level by
dose protraction is three times that found in CLL
and LS (see Fig. 7). In the latter groups, dose
protraction should not, according to this analysis,
decrease the effectiveness of the total dose as
much as in the "normal" group and as, to a lesser
extent, it will in the CNL group. These interpre-
tations implied by the analyticaI results agree
well with most clinicaI observations and suggest,
in keeping with experimental observations, that
normal tissues are spared more than abnormal ones
by dose protraction. This concept is in fact the
rationale for fractionation and protraction of
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radiationtherapyof malignanttissuesadmidst
normalones. Theseobservedifferencesin
peripheralWBCsurvival,after the sameradiation
exposure,probablyresult morefromdifferent
efficienciesof recoverymechanismsthanfrom
inately different cellular radiosensitivitiesin
thesediseases(ref. 29).
It is commonlyassumedthat hematologic
effects reflectedby changesin peripheralblood
countscorrelatequantitativelywith lethality.
Thiscorrelation,however,hasnotbeendemonstrated
either clinically or experimentally.Therefore,a
regressionmodelfor theeffect of dose-rateupon
hematologicparameters,uchasbloodgranulocyte
leyels_cannotbeusedwithmuchassuranceasthe
regressionmodelrelatingdose-rateandlethality.
Theobverseis alsotrue. Bateman(ref. 31),how-
ever,hasshownwell, at least in myopinion,that
dose-rate data for such end effects as human dermal
responses, and lethality of mouse, rat, swine, and
sheep can be fit as a linear function of the recip-
rocal cube root of dose rate. This empirical
observation stems in large part from the way the
Strandqvist model and its numerous modifications
all approximate the power-function exponent of
0.33. Applying the model to the data of others
where a dose-rate effect is easily demonstrable,
Bateman showed that:
=
EDR1 D
= (i+ k )
R 1
where D = is the single dose requirement when
exposure is at an infinitely rapid rate, EDR1 is
the isoeffective dose at some lesser rate (R1).
The size of k, the slope constant for dose-rate
effect as a function of the cube root of R, seems
to be related to the size of the single-exposure
I0.0
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_ 0.1
I
I'
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Figure 7. Graph of the rate of blood cell recovery predicted by
the Yuhas multifactorial dose - WBC response model based on
clinical data of total-body irradiated patients with no marrow
disease ("most normal"), chronic granulocytic leukemia (CGL),
chronic lymphocytic leukemia (CLL), and lymphosarcoma (LS).
The data have been normalized to relative isoeffective marrow
dose for two-day protraction for each set to compare the relative
doubling times (straight arrows) in terms of exposure duration:
7 days, normal; 9 days, CGL; 22 days, CLL; and 42 days, LS.
dose given at conventionally rapid (therapeutic)
rates. The size of k also expresses the recovery
kinetics of the animal species and the cellular
system involved. For example, in Bateman's study
of lethality, k was 1.6 for swine, a species known
to have remarkably efficient total-body repair,
and 0.65 for sheep, an animal model of slow, in-
efficient radiation repair kinetics. Also,
apparently the more radiosensitive a biologic
system is (i.e., the smaller the dose is that is
required to be effective) the less well it repairs
the effects of this small dose; thus the size of k
is variable within the same species, as it depends
on the specific recovery mechanisms and kinetics
of the damaged biologic system.
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The Bateman model was used to construct a
nomogram for human dose-rate tolerance using some
of the biologic end points whose derivation and
validity have been discussed above. This nomogram
is shown in Fig. 8. Some of the assumptions are
based on animal observations when normal human
observations are not available. The extrapolations
extend beyond i00 days even though the observations
upon which they are based do not extend this far.
They are extended to a year in the figure to cor-
respond to the temporal requirement of deep-space
exploration. Extrapolations of clinical data using
the models of Strandqvist, Yuhas, and Casarett
(refs. 32, 53) do not fit this reciprocal of the
cube root scale of dose rate beyond one to three
months after which they curve rapidly upward, away
from the lines shown in the figure, indicating
8gain perhaps the surprisingly great reparabilit Z
that most tissues have of acute radiation damage
induced at extremely low dose rates. Such a con-
clusion is, however, too optimistic for occupa-
tional radiation protection and long-mission
planning guidelines since it predicts that no dis-
cernible acute responses will occur in marrow, gut,
or skin below rather high dose-rate thresholds.
In the absence of much objective clinical support
for the quantitative relations implied by the
nomogram, such reparability on the part of all
men cannot be assumed. Even so, the extrapolations
for the dose-rate response relation of infertility
and sterility, severe hematologic effects, and
hematopoietic death shown in the figure are more
conservative than those of the Yuhas model, for
example, as shown in Figure 7, that predict a
ninefold increase in an isoeffective dose for
hematologic damage to normal human marrow if
exposure were fractionated over a 5-month period.
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Until we obtain additional evidence that
normal human marrow can actually repair as rapidly
as this, the clinically conservative approach is to
accept the worst predictions of the model; the
doubling times of 21 to 42 days for CLL and LS,
which, interestingly enough, approximate the rate
that the Bateman model predicts in the nomogram
(Fig. 8) by the line for "severe" hematologic
response for patients.
In the dose-rate nomogram the accumulated
isoeffective exposures are shown in the figure in
R of photons. The encircles star, _, however, along
with the line for "Late Effects," which has no slope,
should be considered as dose in rem. The Late
Effects lines are intended to define on the nomo-
gram tile dose-rate tolerance boundary or the safe
occupational upper limits for human tolerance to
low-dose-rate exposure if remote and late effects,
rather than prompt effects, must be considered
(ref. 34). The other steeper lines in the nomo-
graph indicate possible dose-rate effect on the
size of accumulated doses for such undesirable
prompt effects as the 50 percent risk of death
within 60 days. Such exposures have a low proba-
bility of ever occurring in space exploration, but,
as we have indicated, are the kind on which we have
the most clinical information. Much more clinical
information, however, is needed before the credit-
ability of any of these lines, their slopes, and
dose-rate relations can be established statistically.
The nomogram does, however, support the opinion
that, except for the remote possibility of some
unforeseen, uncontrollably large exposure, man is
more than sufficiently radioresistant to make the
risks of an early acute radiation effect on one
short space mission intangibly small in relation
to the other non-radiation risks involved.
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Figure 8. A nomogrampredicted by the Bateman model of the effect
of one-day, one-month, three-month, and one-year-long exposures
on the size of accumulated exposure required to produce constant
levels of several kinds of somatic damage; 60-day lethality,
severe damage to normal marrow, assuming man and sheep are equally
radiosensitive large animals. The smaller asterisk at _1000 R on
the S-month isotime line locates the Mexican radiation accident
survivor (see text). The lines for severe marrow damage are
extrapolated from clinical data points (solid circles) and
computed points (open circles) to show damage to diseased marrow,
temporary (reparable) cessation of sperm production, reduced male
fertility and late effects such as increased rate of cancer
induction. The largest asterisk represents the original LDs0/60
estimate for man and has a regression line with a slope
constant k = 0.65 running through it. Constants (k) are assumed
of 0.24 for the recovery capability of diseased and 2 x 0.24 for
for normal hematopoietic systems. The lines for sterility and
low fertility are based on the human data (ref. IS [solid circles])
and canine data (small asterisks) on the one-year isotime line of
Casarett and Hursh (refs. 52 and 33). The "Late Effects" lines
are extracted from the Space Science Board Report (ref. 54).
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